No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NVAX Novavax
- 8.700
- +0.020+0.23%
Close Dec 20 16:00 ET
- 8.740
- +0.040+0.46%
Post 20:01 ET
1.39BMarket Cap-3.99P/E (TTM)
8.888High8.370Low6.09MVolume8.590Open8.680Pre Close52.90MTurnover4.25%Turnover RatioLossP/E (Static)160.18MShares23.86052wk High-2.65P/B1.25BFloat Cap3.53252wk Low--Dividend TTM143.39MShs Float331.680Historical High--Div YieldTTM5.96%Amplitude3.532Historical Low8.688Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Peering Into Novavax's Recent Short Interest
B.Riley Financial Maintains Novavax(NVAX.US) With Buy Rating, Maintains Target Price $22
Novavax's Strategic Partnerships and Pipeline Developments Drive Buy Rating With Promising Long-term Growth Potential
Express News | Novavax- Agreed to Updated Delivery Schedule for Potential Delivery of Covid-19 Vaccine/Future Variant Covid-19 Vaccine Through End of 2029
Express News | Novavax- Acknowledged Commonwealth Cancellation of Delivering Certain Doses of Co’s Covid-19 Vaccine Scheduled for Delivery Between Q4 2023 & Q4 2025
Express News | Novavax Inc - on Dec 12, Entered Amendment 5 to Advanced Purchase Agreement With Commonwealth of Australia
Heat List
US
Overall
Symbol
Price
% Chg
No Data